Clinical trial
A Postmarket Surveillance Registry of the BioMatrix Drug-eluting Stent
NCT01254487 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Postmarket Surveillance Registry of the BioMatrix Drug-eluting Stent
- Lead sponsor
- Biosensors Europe SA
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- September 30, 2014
- Enrollment
- 1,121 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.